Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

637
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
637
Cause and Effect01:53

Cause and Effect

12.0K
While variables are sometimes correlated because one does cause the other, it could also be that some other factor, a confounding variable, is actually causing the systematic movement in our variables of interest. For instance, as sales in ice cream increase, so does the overall rate of crime. Is it possible that indulging in your favorite flavor of ice cream could send you on a crime spree? Or, after committing crime do you think you might decide to treat yourself to a cone?
12.0K
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

564
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
564
Blinding01:11

Blinding

3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Blind Procedures02:07

Blind Procedures

12.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.8K
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

1.1K
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same author

A SIMPLE AND POWERFUL TEST OF VACCINE WANING.

American journal of epidemiology·2026
Same author

5-HT<sub>1A</sub> receptor blockade potentiates the subjective effects of DMT.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Counterfactual Harm: A Counter-argument.

American journal of epidemiology·2026
Same author

Are Psychedelics Ethically Exceptional After All? Some Further Reflections.

The American journal of bioethics : AJOB·2026

Related Experiment Video

Updated: Jan 8, 2026

How to Detect Amygdala Activity with Magnetoencephalography using Source Imaging
10:48

How to Detect Amygdala Activity with Magnetoencephalography using Source Imaging

Published on: June 3, 2013

22.7K

Causal Inference in Studies with Functional Unmasking: Psychedelics and Beyond.

Gabriel Loewinger1, Mats J Stensrud2, Sandeep M Nayak3

  • 1Machine Learning Core, National Institute of Mental Health.

Medrxiv : the Preprint Server for Health Sciences
|December 19, 2025
PubMed
Summary
This summary is machine-generated.

Functional unmasking in mental health trials, especially with psychedelics, challenges outcome interpretation. Causal inference methods can help isolate true treatment effects from placebo effects caused by participants knowing their treatment.

Keywords:
causal inferencepsychedelicspsychiatryrandomized controlled trialssemi-parametric mediation analysis

More Related Videos

Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics
08:16

Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics

Published on: July 23, 2020

2.6K
Investigating the Neural Mechanisms of Aware and Unaware Fear Memory with fMRI
12:51

Investigating the Neural Mechanisms of Aware and Unaware Fear Memory with fMRI

Published on: October 6, 2011

13.6K

Related Experiment Videos

Last Updated: Jan 8, 2026

How to Detect Amygdala Activity with Magnetoencephalography using Source Imaging
10:48

How to Detect Amygdala Activity with Magnetoencephalography using Source Imaging

Published on: June 3, 2013

22.7K
Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics
08:16

Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics

Published on: July 23, 2020

2.6K
Investigating the Neural Mechanisms of Aware and Unaware Fear Memory with fMRI
12:51

Investigating the Neural Mechanisms of Aware and Unaware Fear Memory with fMRI

Published on: October 6, 2011

13.6K

Area of Science:

  • Clinical Psychology
  • Psychopharmacology
  • Biostatistics

Background:

  • Functional unmasking, where participants identify their treatment, is a significant challenge in clinical trials.
  • This issue is particularly pronounced in psychedelic research due to the distinct acute effects of these substances.
  • Uncertainty arises regarding whether observed outcomes stem from therapeutic properties or placebo effects.

Purpose of the Study:

  • To present a counterfactual framework for understanding functional unmasking.
  • To highlight limitations of existing statistical and experimental designs in addressing unmasking.
  • To demonstrate the application of causal inference methods for isolating treatment effects.

Main Methods:

  • Developed a counterfactual conceptualization of functional unmasking.
  • Applied modern causal inference techniques to address treatment effect contamination.
  • Analyzed feedback mechanisms between perceived benefits and expectancies.

Main Results:

  • Existing methods may obscure or exaggerate therapeutic benefits due to unmasking.
  • Identified feedback loops between perceived benefits and participant expectancies.
  • Demonstrated how causal inference can isolate treatment effects from unmasking bias.

Conclusions:

  • Functional unmasking poses a critical challenge in mental health clinical trials, especially for psychedelics.
  • Causal inference offers a robust approach to mitigate unmasking's impact on treatment effect estimation.
  • This work motivates improved trial designs and statistical methodologies for more accurate therapeutic outcome assessment.